Introduction
============

For several decades trypanosomosis has continued to contribute adversely to the economic and social well being of sub-Saharan Africans (WHO, 2006\[[@R25]\]; Adeyemi et al., 2009\[[@R3]\]). This scourge remains a pressing challenge especially to African medical scientists for possible action plan that would include both preventive measures and treatment modalities (Okochi et al., 2003\[[@R20]\]). African trypanosomes cause trypanosomosis, known as sleeping sickness and nagana in man and animals respectively. The trypanosome species affecting man and his domestic animals have been subdivided into two groups, the haematinic group (*Trypanosoma congolense*, *T. vivax*) which remains in the plasma and the tissue invading group (*T. brucei*, *T. evansi, T. gambiense, T. rhodesiense and T. equiperdum*) found in extra and intra vascular spaces (Abubakar et al., 2005\[[@R1]\]; Chretien and Smoak, 2005\[[@R6]\]; Ngure et al., 2008\[[@R18]\]). Because of their presence in the blood, these invading parasites produce numerous changes in the cellular and biochemical constituents of blood (Igbokwe and Mohammed, 1992\[[@R15]\]; Taiwo et al., 2003\[[@R23]\]). *Trypanosoma brucei* infection like other trypanosome infections precipitate increased red blood cell destruction which results in anaemia as well as tissue damage (Ekanem and Yusuf, 2008\[[@R12]\]; Akanji et al., 2009\[[@R4]\]). These changes together with the need by the host to destroy the parasite are presumably responsible for the symptoms of African sleeping sickness. The application of antitrypanosomal drugs has been the most widely practised means of controlling trypanosomosis in domestic livestock since the early 1950s, either as curative or prophylactic drugs. Thus, control of trypanosomosis may depend in the nearest future on the use of the existing trypanocides. The challenge, therefore, remains to make optimal use of the three relatively old compounds until new methods of treatment emerge (Adamu et al., 2009\[[@R2]\]). In this study, we have investigated the effects of two veterinary drugs; novidium® (homidium chloride) and berenil® (diminazene aceturate) on haematological parameters and protein concentrations in rats experimentally infected with *T. brucei.*.

Materials and Methods
=====================

24 male albino rats of average weight between 200-220 g were obtained from the Animal Laboratory Unit of the Department of Biochemistry, University of Ilorin, Nigeria. The rats were randomly distributed into four (4) groups of six (6) animals each. They were kept in clean cages with access to clean water and commercial rat pellets *ad libitum.* The principles governing the use of laboratory animals as laid out by the University of Ilorin Committee on Ethics for Medical and Scientific Research were duly observed.

Parasite
--------

*Trypanosoma brucei*was obtained from the Nigerian Institute for Trypanosoma Research (NITR), Vom - Jos, Nigeria. The parasite was injected into uninfected rats intraperitoneally and maintained in other rats by repeated passaging. Parasitaemia was monitored by preparing a thin film of blood obtained from animal tail and viewing under light microscope at x100 magnification according to the method of Adeyemi et al. (2009\[[@R3]\]).

Drugs
-----

Drugs were dissolved and reconstituted in distilled water according to manufacturer\'s instructions, and administered to animals intraperitoneally (I.P.) in the following concentrations: Homidium chloride (Novidium® 17 rue Bourgelat 69002 Lyon-France): 1.0 mg/kg and Diminazene aceturate (Berenil®, Hoechst, Germany): 3.5 mg/kg.

Animals were inoculated with parasites and infection was allowed to develop for 72 hours before treatment was initiated on day 4. Animals were checked daily (one day before therapy and thereafter for 12 days) for parasitaemia in blood collected from tail vein.

Treatment of animals
--------------------

The animals were divided as follows and received appropriate dosages of the drug that corresponded to their body weight:

Group 1 - Positive Control received appropriate dosages of the vehicle for drug administrationGroup 2 - Negative Control were infected with an inoculum containing *T. brucei*parasites and received no drug treatmentGroup 3 - Infected with an inoculum containing *T. brucei*parasites and treated with homidium chlorideGroup 4 - Infected with an inoculum containing T. brucei parasites and treated with diminazene aceturate.

The treatment with drugs started on the first day the parasites were sighted in the blood. All animals were sacrificed on the 12^th^ day post infection.

Inoculation of rats with parasite
---------------------------------

Parasite infected blood was obtained from the tail of infected rats at high parasitaemia and used to maintain parasite suspension in 0.90 % saline solution which was inoculated into the peritoneal cavity of uninfected rats weighing approximately between 200-220 g. The suspension - as described by Ekanem et al. (2005\[[@R11]\]) and Adeyemi et al. (2009\[[@R3]\]) - contained 3 or 4 trypanosomes per view at x100 magnification.

Tissue collection and preparation
---------------------------------

Collection of sample for biochemical analyses was as described previously (Yakubu et al., 2005\[[@R26]\]). Rats were anaesthetized in slight chloroform and blood samples collected into clean, dry centrifuge tubes. The blood samples were allowed to stand for 10 minutes at room temperature and then centrifuged at 1000 rpm for 15 minutes on laboratory centrifuge (SM 800B, Surgifriend Medicals, England). The supernatant (serum) was carefully removed with Pasteur pipette, and stored frozen until needed for further analyses. The tissues (liver, kidney and brain) were excised and transferred into ice-cold 0.25 M sucrose solution. The tissues which were weighed and finely cut with clean sterile blade were homogenized in ice-cold 0.25 M sucrose solution \[1:5w/v\] using mortar and pestle. The homogenates were kept frozen overnight before analyses. Blood used for haematological analysis was collected into heparinized sample bottles and taken for analyses within 24 hours of collection.

Biochemical analysis
--------------------

Serum and tissue total protein as well as albumin were analysed using the biuret and bromocresol green methods, respectively. In both cases, methods according to Gornall *et al*., (1949\[[@R13]\]) and Doumas *et al*., (1971\[[@R8]\]) were employed respectively.

Haematological studies
----------------------

Blood parameters including packed cell volume (PCV), white blood cell (WBC), neutrophil, lymphocytes and eosinophil counts were determined using the Automated Haematologic Analyzer, Sysmex, KX-21 (Japan) as described by Dacie and Lewis, (1991\[[@R7]\]).

Statistical analysis
--------------------

The group mean ± S.E.M. was calculated for each analyte and significant difference between means evaluated by analysis of variance (ANOVA). Post test analysis was done using the Tukey multiple comparison tests. Values of P\<0.05 were considered as statistically significant.

Results
=======

Table 1[(Tab. 1)](#T1){ref-type="fig"} presents results for haematological indices. Haematological observations of animals in the negative control group revealed low counts of PCV, WBC, neutrophil, lymphocytes and eosinophil which were significantly different (P\<0.05) from the positive control and treatment groups. In contrast, increased protein and albumin concentrations (Table 2[(Tab. 2)](#T2){ref-type="fig"} and 3[(Tab. 3)](#T3){ref-type="fig"} respectively) were observed in the negative control group compared to positive control and treatment groups (P\<0.05). Albumin concentrations in the animals treated with both drugs (novidium® and berenil®) however resulted in decreased concentrations compared to positive control group (P\<0.05).

Discussion
==========

It has been established that the measurement of anaemia gives a reliable indication of the disease status and productive performance of trypanosome infected animals (Ekanem et al., 2005\[[@R11]\], 2006\[[@R10]\]). Trypanosome infection may cause anaemia as a result of massive erythrophagocytosis by an expanded and active mononuclear phagocytic system (MPS) of the host (Igbokwe and Nwosu, 1997\[[@R16]\]). Haematological results obtained in this study agree with earlier studies (Anosa, 1988\[[@R5]\]; Igbokwe et al., 1994\[[@R14]\]; Ekanem et al., 2008\[[@R9]\]). The low PCV observed in the infected group may be as a result of acute haemolysis due to growing infection. Previous studies have shown that infection with trypanosomes resulted in increased susceptibility of red blood cell membrane to oxidative damage probably as a result of depletion of reduced glutathione on the surface of the red blood cell (Igbokwe et al., 1994\[[@R14]\], 1996\[[@R17]\]; Taiwo et al., 2003\[[@R23]\]; Akanji et al., 2009\[[@R4]\]). Severity of anaemia usually reflects the intensity and duration of parasitaemia. Several reports (Ogunsanmi and Taiwo, 2001\[[@R19]\]; Umar et al., 2007\[[@R24]\]; Ekanem et al., 2008\[[@R9]\]; Saleh et al., 2009\[[@R22]\]) have also ascribed acute anaemia in trypanosomosis to proliferating parasites. The lower counts of WBC, lymphocytes and neutrophil observed in the infected negative control group may be attributed to the immunosuppressive actions of trypanosome infection (Abubakar et al., 2005\[[@R1]\]; Ekanem and Yusuf, 2008\[[@R12]\]). Leucocytosis which may be due to lymphocytosis has been implicated in trypanosomosis and these conditions are usually as a result of wax and wear syndrome on the animal immune system caused by the ever changing variable surface glycoprotein of the infecting trypanosomes (Abubakar et al., 2005\[[@R1]\]). In contrast these lesions were reduced significantly in the infected animals treated with novidium® and berenil®. Results suggest that administered drugs improved blood components possibly by depletion of proliferating parasites. High protein concentrations observed in the infected animals agree with previous reports (Orhue et al., 2005\[[@R21]\]; Ekanem and Yusuf, 2008\[[@R12]\]). Increase in total protein and albumin concentrations in the serum of infected negative control animals could be as a result of cell derived proteins due to haemolysis which is secondary to infection. It may also be attributed to increase in parasite mass proteins and/or released intracellular enzymes due to increasing parasitaemia or lysis of parasites by host immune system respectively. Synthesis of immunoglobulin in response to infection may have also contributed to the observed increases in protein concentration. Progressive anaemia is a common pathogenic characteristic of *T. brucei*infection in mammals (Anosa, 1988\[[@R5]\]) thus release of erythrocytes-derived enzymes and proteins may be one possible source of plasma protein. Protein loss from tissues may also have contributed to the increased protein concentrations observed. High protein and albumin concentrations in tissues may indicate increased protein synthesis due to increased protein need secondary to infection and or symptom of cytolysis as the infection progressed. These changes however were reduced (P\<0.05) in the treatment group suggesting attempts by the administered drugs to restore cellular functions to the pre-infection state. The increased WBC, lymphocyte and neutrophil counts (Table 1[(Tab. 1)](#T1){ref-type="fig"}) are indicative of increased host action in the presence of administered drugs against the infection. These boosts will contribute to the development of phagocytes and antibodies against the recognisable antigens of parasite origin. In conclusion, we have provided evidence that the administered drugs (novidium® and berenil®) have potentials for modulating the state of anaemia and immunosuppressive conditions in trypanosome infected rats.
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